Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, International Non-interventional, Observational Cohort Study to Observe Long-term Treatment Patterns and Real-word Outcomes in PAH Group I Patients Previously Participating in TripleTRE - TripleTRE-NIS

NCT06445673 is registered in ClinicalTrials.gov with AOP Orphan Pharmaceuticals AG as lead sponsor.

NCT NCT06445673
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06445673 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, International Non-interventional, Observational Cohort Study to Observe Long-term Treatment Patterns and Real-word Outcomes in PAH Group I Patients Previously Participating in TripleTRE - TripleTRE-NIS
Lead sponsor
AOP Orphan Pharmaceuticals AG
Phase
Observational
Overall status
Enrolling by invitation
Start date
July 31, 2024
Completion date
June 30, 2030
Enrollment
110 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary arterial hypertension